FMP
NASDAQ
1.58 USD
0.08 (5.06%)
Mr. Mark A. Emalfarb
Healthcare
Biotechnology
https://www.dyadic.com
NASDAQ
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validat...
0001213809
US26745T1016
26745T101
140 Intracoastal Pointe Drive
561 743 8333
US
7
Jan 16, 2008
0001213809
NASDAQ
Biotechnology
Healthcare
26745T101
US26745T1016
US
1.58
0.57
24.32k
45.52M
-
1.19-2.4
2.4
-
-
-
-
-6.87
-
https://www.dyadic.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.